RSS-Feed abonnieren
DOI: 10.1055/s-0039-1688835
Use of an Expanded Polytetrafluoroethylene (ePTFE) Dura Substitute in Glioma Surgeries: A Technical Note
Uso do substituto dural politetrafluoroetileno expandido (ePTFE) em cirurgias de gliomas: Uma nota técnicaPublikationsverlauf
14. Februar 2019
08. April 2019
Publikationsdatum:
31. Mai 2019 (online)
Abstract
Introduction Reoperations are a common scenario among glioma patients. There is crescent evidence of its benefit in low- and high-grade gliomas. Here we discuss our experience with inert expanded polytetrafluoroethylene (ePTFE) dura substitute in glioma surgeries.
Technical note We generally put the ePTFE dura substitute below the dura of the patient, even if it is intact. This membrane should be sutured in place using a tension-free technique, with 4-0 polypropylene. Expanded polytetrafluoroethylene minimizes tissue attachment and fibrosis when performing reoperation in glioma patients.
Discussion Since the literature has shown benefits in survival with reoperation in glioma patients, the use of ePTFE dura substitute can improve surgical time and minimize complications in a second surgery.
Resumo
Introdução Reoperações são comuns entre pacientes portadores de glioma, com crescente evidenência de seu benefício em casos de baixo e alto graus. Aqui discutimos nossa experiência com o substituto dural politetrafluoroetileno expandido (ePTFE) em cirurgias de glioma.
Nota técnica Geralmente colocamos o substituto dural ePTFE abaixo da dura-máter do paciente, mesmo quando intacta. Essa membrana deve ser suturadasem tensão com fio prolene 4.0. ePTFE minimiza aderência tecidual e fibrose, facilitando as reoperações em pacientes com glioma.
Discussão Haja vista a melhora da sobrevida em pacientes com glioma submetidos a reoperações já demonstrada na literatura, o uso do dusbtituto dural ePTFE pode diminuir o tempo cirúrgico e minimizar complicações em reoperações.
-
References
- 1 Uppstrom TJ, Singh R, Hadjigeorgiou GF, Magge R, Ramakrishna R. Repeat surgery for recurrent low-grade gliomas should be standard of care. Clin Neurol Neurosurg 2016; 151: 18-23
- 2 Komotar RJ, Starke RM, Connolly ES, Sisti MB. Evaluating the benefit of repeat surgery for recurrent glioblastoma multiforme. Neurosurgery 2010; 67 (06) N16-N17
- 3 D'Amico RS, Cloney MB, Sonabend AM. , et al. The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurg 2015; 84 (04) 913-919
- 4 Park JK, Hodges T, Arko L. , et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 2010; 28 (24) 3838-3843
- 5 Duffau H. . Taillandier Luc. New individualized strategies in DLGG. In: Diffuse Low-Grade Gliomas in Adults (435–443). Springer, Verlag; London: 2013
- 6 Kaspera W, Majchrzak K, Bobek-Billewicz B. , et al. Reoperations of patients with low-grade gliomas in eloquent or near eloquent brain areas. Neurol Neurochir Pol 2013; 47 (02) 116-125
- 7 Lacroix M, Abi-Said D, Fourney DR. , et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95 (02) 190-198
- 8 Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 1987; 21 (05) 607-614
- 9 Barker II FG, Chang SM, Gutin PH. , et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998; 42 (04) 709-720 , discussion 720–723
- 10 Harsh IV GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987; 21 (05) 615-621
- 11 Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg 1993; 36 (03) 271-275
- 12 Chen MW, Morsy AA, Liang S, Ng WH. Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore. World Neurosurg 2016; 87: 439-445
- 13 Görtler M, Braun M, Becker I, Roggendorf W, Heiss E, Grote E. Animal experiments with a new dura graft (polytetrafluorethylene)--results. Neurochirurgia (Stuttg) 1991; 34 (04) 103-106
- 14 Yamagata S, Goto K, Oda Y, Kikuchi H. Clinical experience with expanded polytetrafluoroethylene sheet used as an artificial dura mater. Neurol Med Chir (Tokyo) 1993; 33 (08) 582-585
- 15 Aliredjo RP, de Vries J, Menovsky T, Grotenhuis JA, Merx J. The use of Gore-Tex membrane for adhesion prevention in tethered spinal cord surgery: technical case reports. Neurosurgery 1999; 44 (03) 674-677 , discussion 677–678
- 16 Inoue HK, Kobayashi S, Ohbayashi K, Kohga H, Nakamura M. Treatment and prevention of tethered and retethered spinal cord using a Gore-Tex surgical membrane. J Neurosurg 1994; 80 (04) 689-693
- 17 Nazzaro JM, Craven DE. Successful treatment of postoperative meningitis due to Haemophilus influenzae without removal of an expanded polytetrafluoroethylene dural graft. Clin Infect Dis 1998; 26 (02) 516-518
- 18 Tekkök IH. Spontaneous spinal cord herniation: case report and review of the literature. Neurosurgery 2000; 46 (02) 485-491 , discussion 491–492